Seattle vaccine startup taking on pharma giant GSK with shingles shot raises $26M Seattle vaccine startup Curevo, which is developing a vaccine against shingles, raised $26 million. The funding comes on the heels… Read More
Vaccine startup Curevo takes on pharma giant GSK, raises $60M for trial of shingles shot Curevo has raised $60 million to develop a new vaccine for shingles, an often-painful condition caused by reactivation of the… Read More
